J0589 HCPCS code: Injection, daxibotulinumtoxina-lanm, 1 unit
J0589 is the HCPCS Level II code for injection, daxibotulinumtoxina-lanm, 1 unit. In 2024 Medicare paid an average of $3.32 per service for J0589 across 122,853 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. In 2024, about 80 clinicians billed Medicare for J0589 for 312 beneficiaries; Michigan, Washington, Florida accounted for 45% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-04-01 |
| Last action effective | 2024-04-01 |
Who bills J0589 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 80 |
| Medicare beneficiaries | 312 |
| States with claims | 9 |
| Share of services in top 3 states (Michigan, Washington, Florida) | 45% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0589, 2024–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2024 | 122,853 | 312 | $4.17 | $3.32 |
States with the most J0589 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Michigan | 16,750 | $3.21 |
| Washington | 14,200 | $3.25 |
| Florida | 13,712 | $3.39 |
| California | 13,515 | $3.35 |
| Texas | 12,372 | $3.30 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Clinical: Data |
| practitioner claims | 300 | Clinical: Data |
Medicare policy articles for this code
- A57114: Billing and Coding: Trigger Point Injections (First Coast Service Options, Inc. (MAC - Part B))
- A57185: Billing and Coding: Botulinum Toxin Injections (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B))
- A57186: Billing and Coding: Botulinum Toxin Injections (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B))
- A57715: Billing and Coding: Botulinum Toxins (First Coast Service Options, Inc. (MAC - Part A, MAC - Part B))
- A57751: Billing and Coding: Trigger Point Injections (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
- A58423: Billing and Coding: Botulinum Toxins (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
- A59707: Billing and Coding: Botulinum Toxin Injections (Wellpoint Federal (MAC - Part A, MAC - Part B))
- A59714: Billing and Coding: Botulinum Toxin Injections (Palmetto GBA (MAC - Part A, MAC - Part B))
- A59726: Billing and Coding: Botulinum Toxins Injections (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
- A59809: Billing and Coding: Botulinum Toxin Injections (WPS Insurance Corporation (MAC - Part A, MAC - Part B))
Covered diagnoses (346 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| G11.4 | Hereditary spastic paraplegia | 8 |
| G24.3 | Spasmodic torticollis | 8 |
| G24.4 | Idiopathic orofacial dystonia | 8 |
| G24.5 | Blepharospasm | 8 |
| G24.8 | Other dystonia | 8 |
| G25.0 | Essential tremor | 8 |
| G43.701 | Chronic migraine without aura, not intractable, with status migrainosus | 8 |
| G43.709 | Chronic migraine without aura, not intractable, without status migrainosus | 8 |
| G43.711 | Chronic migraine without aura, intractable, with status migrainosus | 8 |
| G43.719 | Chronic migraine without aura, intractable, without status migrainosus | 8 |
Showing 10 of 346. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J0589
- 2024-04-01: J0589 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0589?
J0589 is the HCPCS Level II code for injection, daxibotulinumtoxina-lanm, 1 unit. Short descriptor: "Inj daxibotulinumtoxina-lanm".
How much does Medicare pay for J0589?
In 2024, the average Medicare payment was $3.32 per service (average allowed $4.17).
Does Medicare cover J0589?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J0589?
Medicare policy articles that cite J0589 list 346 covered ICD-10-CM diagnosis codes across 10 articles. The most cited include G11.4 (Hereditary spastic paraplegia), G24.3 (Spasmodic torticollis), G24.4 (Idiopathic orofacial dystonia). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J0589 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J05 codes
- J0500 — Injection, dicyclomine hcl, up to 20 mg
- J0515 — Injection, benztropine mesylate, per 1 mg
- J0517 — Injection, benralizumab, 1 mg
- J0520 — Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525 — Injection, cefotetan disodium, 10 mg
- J0528 — Injection, fosfomycin disodium, 20 mg
- J0558 — Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561 — Injection, penicillin g benzathine, 100,000 units
- J0565 — Injection, bezlotoxumab, 10 mg
- J0567 — Injection, cerliponase alfa, 1 mg
- J0570 — Buprenorphine implant, 74.2 mg
- J0571 — Buprenorphine, oral, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0589
- Watch J0589 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0589
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.